PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $915,463 | +39.3% | 935,000 | 0.0% | 0.12% | +32.6% |
| Q1 2023 | $657,183 | -19.7% | 935,000 | 0.0% | 0.09% | -39.1% |
| Q4 2022 | $817,934 | -1.5% | 935,000 | 0.0% | 0.15% | +3.4% |
| Q3 2022 | $830,000 | +4.4% | 935,000 | 0.0% | 0.15% | +9.8% |
| Q2 2022 | $795,000 | -4.1% | 935,000 | 0.0% | 0.13% | +35.7% |
| Q1 2022 | $829,000 | -2.8% | 935,000 | 0.0% | 0.10% | +6.5% |
| Q4 2021 | $853,000 | +4.9% | 935,000 | 0.0% | 0.09% | +4.5% |
| Q3 2021 | $813,000 | -5.9% | 935,000 | 0.0% | 0.09% | -5.4% |
| Q2 2021 | $864,000 | – | 935,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 37,825,000 | $25,876,000 | 3.78% |
| PenderFund Capital Management Ltd. | 13,060,000 | $9,300,000 | 3.13% |
| Telemetry Investments, L.L.C. | 1,500,000 | $1,084,000 | 3.13% |
| Context Capital Management, LLC | 1,600,000 | $1,157,000 | 0.66% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,750,000 | $20,019,000,000 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,750,000 | $2,712,000 | 0.08% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,182,000 | $5,264,000 | 0.04% |
| AQR Arbitrage LLC | 3,050,000 | $2,236,000 | 0.03% |
| Teton Advisors, Inc. | 400,000 | $280,000 | 0.03% |
| GABELLI FUNDS LLC | 3,750,000 | $2,629,000 | 0.02% |